Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice

被引:1403
作者
Nitta, T
Hata, M
Gotoh, S
Seo, Y
Sasaki, H
Hashimoto, N
Furuse, M
Tsukita, S [1 ]
机构
[1] Kyoto Univ, Fac Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Fac Med, Dept Neurosurg, Sakyo Ku, Kyoto 6068507, Japan
[3] KAN Res Inst, Shimogyo Ku, Kyoto 6068317, Japan
[4] Kyoto Prefectural Univ Med, Dept Physiol, Kamigyo Ku, Kyoto 6020841, Japan
[5] Jikei Univ, Sch Med, Inst DNA Med, Dept Mol Cell Biol,Minato Ku, Tokyo 1058461, Japan
关键词
tight junction; central nervous system; endothelial cells; blood vessel; drug delivery;
D O I
10.1083/jcb.200302070
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tight junctions are well-developed between adjacent endothelial cells of blood vessels in the central nervous system, and play a central role in establishing the blood-brain barrier (131313). Claudin-5 is a major cell adhesion molecule of tight junctions in brain endothelial cells. To examine its possible involvement in the BBB, claudin-5-deficient mice were generated. In the brains of these mice, the development and morphology of blood vessels were not altered, showing no bleeding or edema. However, tracer experiments and magnetic resonance imaging revealed that in these mice, the 131313 against small molecules (<800 D), but not larger molecules, was selectively affected. This unexpected finding (i.e., the size-selective loosening of the BBB) not only provides new insight into the basic molecular physiology of 131313 but also opens a new way to deliver potential drugs across the 131313 into the central nervous system.
引用
收藏
页码:653 / 660
页数:8
相关论文
共 43 条
  • [1] Delivery of imaging agents into brain
    Abbott, NJ
    Chugani, DC
    Zaharchuk, G
    Rosen, BR
    Lo, EH
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1999, 37 (1-3) : 253 - 277
  • [2] ANDERSON JM, 1995, AM J PHYSIOL, V269, P467
  • [3] Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein
    Balda, MS
    Whitney, JA
    Flores, C
    Gonzalez, S
    Cereijido, M
    Matter, K
    [J]. JOURNAL OF CELL BIOLOGY, 1996, 134 (04) : 1031 - 1049
  • [4] Balda MS, 1998, J CELL SCI, V111, P541
  • [5] Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications
    Caravan, P
    Ellison, JJ
    McMurry, TJ
    Lauffer, RB
    [J]. CHEMICAL REVIEWS, 1999, 99 (09) : 2293 - 2352
  • [6] CHANLING T, 1992, AM J PATHOL, V140, P1121
  • [7] COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos
    Chen, YH
    Merzdorf, C
    Paul, DL
    Goodenough, DA
    [J]. JOURNAL OF CELL BIOLOGY, 1997, 138 (04) : 891 - 899
  • [8] MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES
    CORDONCARDO, C
    OBRIEN, JP
    CASALS, D
    RITTMANGRAUER, L
    BIEDLER, JL
    MELAMED, MR
    BERTINO, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) : 695 - 698
  • [9] Drug delivery via the blood-brain barrier
    Edwards, RH
    [J]. NATURE NEUROSCIENCE, 2001, 4 (03) : 221 - 222
  • [10] Ehrlich P, 1885, THESIS BERLIN, P69